Example: Heart Attack

Clinical Trials Sponsored by Cerenis Therapeutics, SA

Total 5 results

    • NCT02697136
      Terminated
      CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases
      Conditions: Familial Hypoalphalipoproteinemia
    • NCT02484378
      Completed
      CER-001 Atherosclerosis Regression ACS Trial
      Conditions: Acute Coronary Syndromes
    • NCT01515241
      Completed
      Exploratory Study of Plaque Regression
      Conditions: Heterozygous Familial Hypercholesterolemia
    • NCT01412034
      Completed
      Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects
      Conditions: Homozygous Familial Hypercholesterolemia
    • NCT01201837
      Completed
      Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
      Conditions: Acute Coronary Syndrome
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations